Home

Balaxi Pharmaceuticals PE Ratio

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

PE

10.8

Last updated on: Dec 26, 2025

Key Highlights

  • The P/E Ratio of Balaxi Pharmaceuticals Ltd is 10.8 as of 26 Dec 15:30 PM .
  • The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 12.1 on March 2020 to 14.1 on March 2025 . This represents a CAGR of 2.58% over 6 years.
  • The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 28.4 as of 26 Dec 15:30 .

Historical P/E Ratio of Balaxi Pharmaceuticals Ltd

No data available

Company Fundamentals for Balaxi Pharmaceuticals Ltd

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

Share Price

₹ 28.4

0.07 (0.25%)

stock direction

Last updated on: Dec 26, 2025

Market Price of Balaxi Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 202528.4
24 Dec 202528.33
23 Dec 202528.9
22 Dec 202528.01
19 Dec 202527.83
18 Dec 202528.11
17 Dec 202528.82
16 Dec 202528.71
15 Dec 202529.04
12 Dec 202530.06

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Balaxi Pharmaceuticals Ltd

Asset Value vs Market Value of Balaxi Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Balaxi Pharmaceuticals Ltd156.79
Sun Pharmaceutical Industries Ltd412494
Divis Laboratories Ltd170514
Torrent Pharmaceuticals Ltd129044
Cipla Ltd121574
Dr Reddys Laboratories Ltd105919

Key Valuation Metric of Balaxi Pharmaceuticals Ltd

X

Historical Market Cap of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Balaxi Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Balaxi Pharmaceuticals Ltd

No data available

* All values are in %

About Balaxi Pharmaceuticals Ltd

  • Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
  • The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

Balaxi Pharmaceuticals Ltd News Hub

Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter

Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as aga

Read more

02 Aug 24

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be he

Read more

01 Aug 24

Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September

Read more

05 Nov 24

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 20

Read more

30 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions